Zealand University Hospital

regionsjaelland.dk

Total trials

230

Active

44

Phase 3

3

Total enrollment

162,708

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 8 of 8 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Cabergoline1
Propranolol1
Influenza vaccine1
Pembrolizumab1
Iron(III)isomaltoside2
Acetylsalicylic acid1
Tigecycline 50 MG1
Amoxicillin Clavulanic 500/125mg or placebo1

Next readouts

  • 2024-03-01
  • 2025-05-01
  • 2025-09-01
  • 2026-12-31
  • 2026-12-31
  • 2028-05-01
  • 2028-10

Top conditions

  • Colorectal Cancer9
  • Anesthesia, Local8
  • Ventral Hernia7
  • Postoperative Pain7
  • Healthy7
  • Quality of Life6
  • Delirium5
  • Obesity5

Frequently asked questions about Zealand University Hospital

How many clinical trials does Zealand University Hospital have on ClinicalTrials.gov?
Zealand University Hospital is listed as the lead sponsor on 230 clinical trials in ClinicalTrials.gov, 44 of which are currently active (recruiting, enrolling, or ongoing).
How many of Zealand University Hospital's trials are in Phase 3?
3 of Zealand University Hospital's trials are in Phase 3, spread across 8 active drug programs.
What therapeutic areas does Zealand University Hospital focus on?
Zealand University Hospital's most-studied conditions on ClinicalTrials.gov are Colorectal Cancer, Anesthesia, Local, Ventral Hernia, Postoperative Pain, Healthy.
When are Zealand University Hospital's next clinical trial readouts?
Zealand University Hospital has 7 upcoming primary-completion readouts tracked here; the soonest is “Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer”, expected around 2024-03-01.